BLMH.c shows promising indicators ahead of quarterly results As we await Bloom Health Partners’ (CSE: BLMH) next quarterly results, there are a couple exciting things to watch for on the chart.
The 50MA has begun to curve upward as shares continue consolidation around $.2. This optimistic sign has me watching for a high volume cross above the moving average.
As quarterly results are expected within the next couple of weeks, these technical indicators could perfectly align with the expected catalyst they will provide. The company is presently valued considerably less than yearly earnings so far. To be exact, the current valuation is 54% of fiscal yearly earnings so far.
This is definitely a stock worth keeping an eye on for a BIG correction IMO.
BLMH.c is currently valued at $9.22 million, trading at $.195.